{"id":1010770,"date":"2026-10-15T16:42:19","date_gmt":"2026-10-15T20:42:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/"},"modified":"2026-10-15T16:42:19","modified_gmt":"2026-10-15T20:42:19","slug":"lb-pharmaceuticals-to-participate-in-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/","title":{"rendered":"LB Pharmaceuticals to Participate in Upcoming Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Oct.  15, 2026  (GLOBE NEWSWIRE) &#8212; LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that members of its executive team will present and participate in the following upcoming investor conferences:<\/p>\n<p align=\"justify\">\n        <strong>Craig-Hallum Biotech Catalyst Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Virtual fireside chat at 10:00 a.m. ET and virtual 1&#215;1 investor meetings on Thursday, October 22, 2026\n<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>Guggenheim Securities 3<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Innovation Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Fireside chat at 1:00 p.m. ET and 1&#215;1 investor meetings on Monday, November 9, 2026, in Boston, MA\n<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>Wolfe Research Healthcare Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">1&#215;1 investor meetings on Tuesday, November 10, 2026, in New York, NY\n<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>Stifel Healthcare Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Fireside chat at 9:20 a.m. ET and 1&#215;1 investor meetings on Thursday, November 12, 2026, in New York, NY\n<\/li>\n<\/ul>\n<p align=\"justify\">Webcasts for the fireside chats will be available on the \u201cInvestors\u201d section\u00a0under the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FEmgkviMU_xUIfRl4nTVclHj78Iqoc_iJ57J8tT1x-pTQdfGqSe85YPSxQ-YcBNdKyBc4qgT1urPkL71Flw5m5X1Lfy-pDfMqFkaaDzSQXO_UnW2Q15_rKB5KgpB-s5Ts4pHJF7a-_GNGmmUbCbBj6HV4Wn1K_YU9Q4N9C7uCuSHjqlF6Cah2veC0m6BBAUazJBu0wK-g-qJCXLsC1KsjoaX1vie9sAL7P7_iP2gT7tOFMngdpPP2Vl-wb4ed62PCy2jyJZbAs_8ob9Yu0DTkXOMt5HFlTGHaLTWRfC7tbESNODW503eYFFmLSag4B7ISGCSXQaUl7X63ckm1STsQuUnMItduPBIRUWUGv9PVErFcZ3zUU5Jtlv4qhVpGK7bap8Bk-O0jNlJLp7-NBYICAVJMRbJmS3bD4pns6fLH2ZQ5AT1mBnoPBUF0y_Orp8BB5KjbyoYEqeaB3ufWz7C_lKThxb7YZgpRmuKWib7ml_PGaDCZUCFHy-6mZLvepMVxVAFHj-QtK8ufgKXqmxFtRQAqdxbJoa-gbCQh4EgyO3MS9FymJ0SEsksWAoQ6oNCV4-IvYE64zCFp-HiViSralG31WAU-8XTB2vxlGlPjkw884iOzUcuPfd1D9nSYNE1tqwmJRj-F_bTXGqTyQq7_GDWKPSkNw87zDiD6TQkS_a5tAXZp1L_XkPMp924kptayGZk3tvQ6_U5lA7qSGoI7pl-J1mxb-lR9hAsa_V2auGWRRSMGFVCq8TYRj45fRXOS0VgvW8XN2gZ6DwxxZwzMzsLPfN1lb63xxpdJrV92MYRpTJ8MVrVe3eLpZ3s6gveR-urHWxbavIepsTayDwcDEdPoNtCrVoRCaWbpR0GpnA3uncO9L8v8TQ9DrB9OpbF2DjuDDk3Q_gtlGG2ss2Sp-sjhqg8nAgq9AuYqYYySBhvaV6d4bWdOUj9XIgC8AvNaeOvGjehnZz8l5C_gEJWQMlZgmyB0-OP5jKrLnsmsEqIoKNKHE7RXbmBomcmLDe76qk2-7-9ejS7ooTKZMykrBC1Covx__vKcvPKslHrugsu0KEG67_fzsvPXCd6JuawAeyh5wPXofmx06l-9WHhYh6b1cnHx6gL_hQh0oX_8Wq-QzdDgLN24Du18VTj0ZVNYJMo6Xr32O9rgm5x7HAk50hjbk1t1o3CgHee5uxYw1WsCz6Fba0PjFWXElRsIFfXud6QRqzgfNJpJH4nd8b-3qP3g_aEeUrupOA6OSLNg4MpbmD5sSYzo7Ojn4nJdPLENw78enbH6STuMf6xFmWN2QOCz11Jl9MCVTtFYCC3ewyMDgqSzqcJ8I0qR_ohFpRHRO8PtJgzB6HZwytenlemwzWMZC3UO-kXbSMrsAP5ggCzRxiMgAG6gMMjyuxcnm4PGDchYCM1_xf0uaUGjd_3PlVHYRFco_8r6SKPnkEM1W3valJGJyhBZr3N07Aj9qGSWqnK3o_g8nIGp8EEfU4AqYsjpYWvywKwEXVw7HUJ0roGAWa1TiH7ZjljbHZutQOBDujY9-u5IQ9MCf-kXYQecPBrV2OS8dzRSsV-G9jI9ljQAbEkVALIfZb4ZCgY_RXfu9mdFZwJrPZbp-Ml6o-oHmQFizL77Y6WVZOTL9Mz5vnnd7rhqV6OPDr5w_nlk8_gy7gb676vhohxQCTZ3zNrIDocpPQ3V52BzZBaMK-tFAGfJY0Jo9bJ25eZ8F6h8aJDC9Z0EDWdL2iOB2sm3ayXLA==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u201d page of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wWqbkcRAMeDheneiAaZZdOSKhDTkHw2UcqTAdoEu1_gcHnXddWNgjQ3eDH_yNetFytAAcRw1Zc_q-giPaZiZFGLbcXmjaGasCvkAeqSwwdVRKXTh5VCPc6jBaHV4YwdTa1wbHbjptcy-5oBo2BqK04QjjVLNEU5se-ZAzSqLDYbyqsGIwNJPcENGLUXhjbgj8v8Ne2QIyMzNq7uST2-Zuhi0O6evJEhUCUgrEav9pSF3TmWhIU-vivGx24cqZuwZcMIsweXOn5TP9YIKpqa8X4QhYvPyeDPGiVHNOW2CPJJ3U5uks9IT1S33yFEw6Q3khb0eb0fCLe_gXl8Gbwdzhsr9XZLKO0-CzI7BN1LR2agDC5CLjY7BmTI1pdlJDLD53ZWc9hIE1TfEwXJ-saLvtOPSHV2YuzXadwx9DTX29zey4vmoCLtFZNLoswKTpMXgOyRxr2olS1uibKrrje8OemEnfIwDhnBZKe8y6nfWj1tWg536koHz65Oo_RjBE3RLx-d2n_zQdcy3S0PLiSt274TzHrwJpPOXrwfYzUcq8ruMATtH7aYrShH0bGbiLhDdqoW5simN8_-KRD4Ldzk8n0UhjzNYoQ6-UubxxBrAV1KWdyulu3Ooi7MOamJ7zHKdmjfElsXnus_bxEKGh8K-UXKYPexNLwxH3zKeG01WU3bg1gcFVaUaGc4E5HYoDwGs468vAYjOX7Pu5_hn79OfyIbV6afJYdKLeB104puBRGDVcAmD9VAKTmgBUGzXrV9Z7t8gJTBaFG9rgSyYYIa4U-iQq2Twi79wK7SW4MaH27s8J32Kyr_xJUHmb8sU9OQ0HvleeItTnuzOKsmtXbazV6lXMjlrcwrbOZhQx1xT7xMUsBbe5xnNIw07AAifniHJbL5uYPti8HWvqLTZtrsv_2z70JzpBbe89bEWR1fWSvA6ljTdZQSiLoQFr3aN-lrQ19jjKhGqEuMaux9OT6hjpBJa5nIs-xVBMCsM3IyidFWY4hwnVCNrmqmSIILTrw_DeLwyr6t9O2kWvvmgXarAXTDbMME533VsT20_KUiq6Nb3PdNH2NXTGuGwrtCHubE1Bz92hgeTgDvp53VjAL8q28XpWwPte3g6yZOns8TrBifwlSTdMwQTN_Z2uOTnzjHtSDFTXE-cU68lR3F8yQ0GoHD4iCFeehTwOPOAgsc18KClFxdmIAMidViiTvcwQq9UQ-Qxcgi87KViWL7YGWQ1MVD4E40epC7F1Wwxg0j_WX0jHF5Dk3heoBKg8K29G0SpAqXsIi8xQvkEo0EE6bci6obGKm2gwR49CnIlIstPQUhGmO7XTobKk9ePqJvkDI7e2GF8thb6G0aoOUPatqQja4RIDClxTMT0owu28Efeeu6c8FJa9D1im8SA5ukX8FdfHBZTF8seRxlrL2hbWCfHw1e9U05KAuHD3oCDaUJXHy9JSRGiR1O7lhG2cxoJK6yQ3nN7HQMT9ToaddEWP2v-0Uv3_m8kODSHWoZ2BE77egx5nhBf0sz_UHMlleG77scitZ42wSCQ5XMq6Bkf1HZGTI904IdPMKIQcIRvIWjGfTAl9myY4IWSlRjWdVAMdcti2Jvkp5D7WqiVLQyXPNfsQyTuIRP3VsAzRnGnnXUkPzDDubXlApjIShKO7sYsrm-cH4tOv8Q7ml5ae6xI3riCO_dM6C18VNKiYK_T3WRNrFZdeJ2rUHAfCFWssbU9ZEPgrbD-kbko0cIcxq7qyJkkhjAboQv5b-UaR-89LwFxm5lWOQYCkzY100NEPRjAhNZYTypMPTeJ3fggSb04PFX0QNnc8aseoKDEsbt-qKOz8al4IA69MpBPzqJNPxkJ-o22GtcSv4vB6-73oFuTFwUYdtCJo-nYD9b47CATo-9i7iA1zBXoUvMQA0mUAyEfkL_BAZTEpm4MIqcoLMYkXY7x9kSTMxilmA4VUm_8jeof016n1y5gNcYdMvQ8P4m3-O8HMkcWiHVA1EXKNJxrSOcAT6eUkXPJtPFEC8Re0_qKMOSpqM0mfj46vKMqbLsPrZkCguvyRygAtLceg7lfQIub_Nqs8rADMSdbp8hRhEq_BBUFIx2sRzh4D-t5fuFya-bSHbTrBdgGNeWQbF7LenIJ_og0irNaLhbtiDA2XAtOU70qPtId6hiuBBjKw0e4b2qjZhGxoB1JVo8r6Ub767Ap7g_xZLWZ7zI5uD4TzUrTng1FABiOtLHKvMPW13VfvNT7t5Ljsp9J9qTTvzTm0UeFl16rwiVxHeLrrbpt2vGXThBkFRURwkrNZ-CtFrcGSFrY1ZWaaG5ENbJe3yzEHFfoIZBtq1tlsUkfftLpz9EKBthdm4ctVG4-vqwqQAeX2CEvcva0LD-YSlW6QaxCZoox1fF0Nb0SV9CFy6HpEh7UO4cPc2Jydk64jHTwEfcXYQ6QvUSgQIYTJ2bXZo6R9xLTJQHV26HmX4FZ-qPhJE27CMUH9Zj_anCLPwzCg_IpRH3T-FaU4udqTj-9rZbwtZq5fQSG6D7YFMu0HZDSpd9QUKIS8it9NadTRdeXN3TI05Ce1pQrK5kYl6eme_2_Ebua7dlrb--qWKuMhfl55BM0Fsxt3nn6vSbnPUnMcnHGu5gUVGTJ8PrjzbWmmxHhYSn5jpN4uEFTAMjxrU9cwZU8H3kmKtzFH5uvV3Jyu96vqqW2CMM8TNy-m4jdAnzMp8UeEXXxK7XvTsBnzh-yjEY7XawzbSDTEIUCTjU0weynjcAYvBC0N6mZ-q0rkNc0X8xbqg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.lbpharma.us\/<\/a>, where a replay of the webcasts will be archived.<\/p>\n<p align=\"justify\">\n        <strong>About LB Pharmaceuticals<\/strong><br \/>\n        <br \/>LB Pharmaceuticals is a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the Company believes has the opportunity to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102, if approved, has the potential to become a mainstay of psychiatric practice by offering a balanced clinical activity and tolerability profile that provides a potentially attractive alternative to branded and generic therapeutics for the treatment of a broad range of neuropsychiatric diseases.<\/p>\n<p align=\"justify\">\n        <strong>Media and Investor Contact<\/strong>:\u00a0<br \/>Ellen Rose<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Eu7ft3W02Kb0mh6Ut9UF87vcSh0TgAR0nn-GKYDBgLfm5UbNhJeEc6aETok2mBrOM1o9LPdLO6u9XPKZKOOhacA6oy3FyzJxdurHSC38HM0=\" rel=\"nofollow\" target=\"_blank\">erose@lbpharma.us<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmQ3MDcxNTMtNmI5Yy00OTU1LWIxZTMtNjZlMDcxYjM1OWM1LTUwMDEzMDE5NS0yMDI2LTEwLTE1LWVu\/tiny\/LB-Pharmaceuticals-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that members of its executive team will present and participate in the following upcoming investor conferences: Craig-Hallum Biotech Catalyst Conference Virtual fireside chat at 10:00 a.m. ET and virtual 1&#215;1 investor meetings on Thursday, October 22, 2026 Guggenheim Securities 3 rd Annual Healthcare Innovation Conference Fireside chat at 1:00 p.m. ET and 1&#215;1 investor meetings on Monday, November 9, 2026, in Boston, MA Wolfe Research Healthcare Conference 1&#215;1 investor meetings on Tuesday, November 10, 2026, in New York, NY Stifel Healthcare &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;LB Pharmaceuticals to Participate in Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010770","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that members of its executive team will present and participate in the following upcoming investor conferences: Craig-Hallum Biotech Catalyst Conference Virtual fireside chat at 10:00 a.m. ET and virtual 1&#215;1 investor meetings on Thursday, October 22, 2026 Guggenheim Securities 3 rd Annual Healthcare Innovation Conference Fireside chat at 1:00 p.m. ET and 1&#215;1 investor meetings on Monday, November 9, 2026, in Boston, MA Wolfe Research Healthcare Conference 1&#215;1 investor meetings on Tuesday, November 10, 2026, in New York, NY Stifel Healthcare &hellip; Continue reading &quot;LB Pharmaceuticals to Participate in Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T20:42:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LB Pharmaceuticals to Participate in Upcoming Investor Events\",\"datePublished\":\"2026-10-15T20:42:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/\",\"name\":\"LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\",\"datePublished\":\"2026-10-15T20:42:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LB Pharmaceuticals to Participate in Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk","og_description":"NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that members of its executive team will present and participate in the following upcoming investor conferences: Craig-Hallum Biotech Catalyst Conference Virtual fireside chat at 10:00 a.m. ET and virtual 1&#215;1 investor meetings on Thursday, October 22, 2026 Guggenheim Securities 3 rd Annual Healthcare Innovation Conference Fireside chat at 1:00 p.m. ET and 1&#215;1 investor meetings on Monday, November 9, 2026, in Boston, MA Wolfe Research Healthcare Conference 1&#215;1 investor meetings on Tuesday, November 10, 2026, in New York, NY Stifel Healthcare &hellip; Continue reading \"LB Pharmaceuticals to Participate in Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-15T20:42:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LB Pharmaceuticals to Participate in Upcoming Investor Events","datePublished":"2026-10-15T20:42:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/","name":"LB Pharmaceuticals to Participate in Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==","datePublished":"2026-10-15T20:42:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjYyOSM3ODk4MTg2IzUwMDEzMDE5NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LB Pharmaceuticals to Participate in Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010770"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010770\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}